Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy eraPaul J. Hampel, Sameer A. Parikh, Saad S. Kenderian et al.|Leukemia|2024Cited by 12
P632: COMPARISON OF TREATMENT-EMERGENT ADVERSE EVENTS OF ACALABRUTINIB AND ZANUBRUTINIB IN CLINICAL TRIALS IN B-CELL MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSISSteven R. Hwang, Yucai Wang, Jacqueline Wang et al.|HemaSphere|2023Cited by 7